Antibiotics have made it possible to treat bacterial infections such as meningitis and
bacteraemia that, prior to their introduction, were untreatable and consequently fatal …

Abstract The ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) …

The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

With the advancements of science, antibiotics have emerged as an amazing gift to the
human and animal healthcare sectors for the treatment of bacterial infections and other …

Acinetobacter baumannii-calcoaceticus complex is the most commonly identified species in
the genus Acinetobacter and it accounts for a large percentage of nosocomial infections …

The spread of bacterial drug resistance has posed a severe threat to public health globally.
Here, we cover bacterial resistance to current antibacterial drugs, including traditional herbal …

Acinetobacter baumannii is a leading cause of nosocomial infections as this pathogen has
certain attributes that facilitate subversion of natural defenses of the human body. A …

The aim of this study was to provide a comparative analysis of chitosan (CH), copper oxide
(CuO), and chitosan-based copper oxide (CH-CuO) nanoparticles for their application in the …

Acinetobacter baumannii is recognized as a clinically significant pathogen causing a wide
spectrum of nosocomial infections. Colistin was considered a last-resort antibiotic for the …

Introduction Although antimicrobials have traditionally been used to treat infections and
improve health outcomes, resistance to commonly used antimicrobials has posed a major …